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 1 
Introduction 
 
From the very ancient period carcinoma breast has been one of the 
most common ailments affecting human civilization. It is the most 
common carcinoma causing death in females in western world whereas it 
is second most common cause next to carcinoma cervix in developing 
world like India
1
. Though carcinoma breast seems easier to diagnose and 
treat but till today it is a challenge for medical professionals to restrain 
this malignant disease.  
The clinical examination, imaging and Fine needle aspiration 
biopsy collectively included in ―Triple assessment technique‖. Both 
sensitivity and specificity of this is 99%. If any of these three modalities 
suggest cancer, excisional biopsy is warranted.  
CLINICAL EXAMINATION  
A proper history and a thorough physical examination is the oldest 
and yet the most useful and indispensable method of diagnosis as said by 
Haagensen CD
3
.  
A clinician who gives importance to the results of newer diagnostic 
methods than physical examination of the breast is bound to make errors. 
Physical examination remains the gold standard and should unequivocally 
be employed as the first line method for diagnosing breast lumps.  
 2 
 
FNAC  
Several irreproachable advantages of FNA cytology in assessment 
of breast lumps, have made it the first line modality in the investigative 
sequence. Some of these advantages are
4
 : excellent patient compliance, 
short time required for planning of surgery and ancillary staging 
investigations without delay, avoidance of surgery in unequivocally 
benign conditions, equitable use of hospital and operation theatre 
facilities with reduction in the need of frozen section, excisional or core 
needle biopsies.  
 
MAMMOGRAPHY  
Roentgenography to identify breast diseases was first used in 1913 
at the University of Berlin. Since then, mammography has been widely 
accepted as a routine examination in the evaluation of breast diseases.  
Mammography, is most widely used methods for detecting early 
breast cancer.  
Mammography is a special type of x-ray, used to create detailed 
images of the breast. Mammography uses low dose x- ray : high contrast - 
high resolution film; and an x-ray system designed specifically for 
imaging the breasts..  
Mammography can identify lesions in impalpable brest lump.  
 3 
ULTRASONOGRAPHY  
Ultrasound is particularly useful in young women with dense breast 
in whom mammograms are difficult to interpret, and in distinguishing 
cysts from solid lesions. It can also be used to localize impalpable breast 
lumps.  
Ultrasound can be used to evaluate abnormalities in breast seen in 
mammography.  Both undetected and detected breast mass by other 
modalities can go for ultrasound guided biopsy. 
 
 
 4 
 
 
Aims of Study  
 
1. To evaluate the various diagnostic modalities in breast mass lesion 
e.g. FNAC, USG, Mammography and Clinical assessment. 
2. Utility and importance of integrated clinical, FNA Cytological, 
mammographical and Ultrasonographical approach in the diagnosis 
and work up of patients with breast mass lesion. 
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Review of Literatue 
HISTORICAL REVIEW  
The earliest medical record available about the tumors and ulcers 
of the breast is Edwin Smith Surgical papyrus [1822-1906], which 
mentions about eight of such cases, this record was written in Egyptian 
pyramid age in old kingdom (3000-2500 BC). This record explains 
cauterization by fine drill technique as practiced by ―Imhotap‖ the oldest 
known physician. 
Another old Egyptian Manuscript ―Ebers Papyrus‖ (1600-1500 
BC) explains the treatment of breast tumor by cautery and then by knife 
with coarctation of skin edge of the wound. 
Another  important  record of ―Herodotus‖, a tumor historian, who 
records the successful treatment of advanced and ulcerated tumors of the 
breast. Attossa, daughter of Cyrus concealed a tumor in her breast for a 
long time till it grew big and ulcerated. When she was sent to 
Demoncedus a famous physician, who is said to have cured her breast 
tumor. This case may be probably be a benign tumor of the breast such as 
cystosarcoma phyllode, said to be cured. The method of treatment was 
not revealed. ‗Hippocratus‘ (5th century BC) who is known as father of 
Medicine, in his work ―Disease of Women‖ describes the origin of the 
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hard tumor of the breast and value of medical, Surgical and Cautery 
treatment in the breast tumors and whether any of the treatment is of real 
benefit or harmful. He says that a knife can cure the tumor which is 
incurable by medicine, and cautery can cure the tumor which is incurable 
by surgery. 
And if all the three cannot cure the tumor then the disease is 
incurable. He knew that a few tumors, in their early stages have got more 
chances of cure than those which are in advanced stage 
        ‗Galen‘, the great scholar of Greece (2nd century AD) the founder of 
―Humeral theory of disease‖ recommended surgery for the tumor of the 
breast which were removable. These  tumors  were, as we asses today 
may be benign or malignant tumors is early stages. He was the one who 
vividly described the cancer of the breast resembling the ―Crab‖ which 
even today forms the symbol of cancer. ‗Leonides‘, a great physician of 
Alexandraian School used the sign of the retraction of the nipple to 
differentiate the malignant tumors from the benign tumors. After nearly a 
thousand years (14th century A.D) ‗Len frank‘, father of French Surgery 
was using leonide‘s method of treatment for breast tumors.(surgical). 
‗Leonard Fushs‘ (1501-1546) and Guy-De-chouliac (1300-1367) were the 
other workers who favored the surgery for tumors of the breast with other 
medical treatment. ‗Mercus Aurelins severimens‘ (1580-1656) school of 
Severino recommended excision of benign tumors of the breast in fear 
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that the possibility of them becoming malignant. ‗Scultetus‘ (1595 – 
1645) a famous illustrator of surgery, devised the quick methods of 
surgery for breast as anaesthesia was undeveloped at that time, quickness 
was the criteria in surgery.  ‗Jean Louis Petit‘ (1674 – 1750) Alexander 
Manro (1773 – 1850), Avela pean 
(1795 – 1867) Sir James Paget (1814 – 1899) and Muller (19th century) 
were the other workers who have contributed much to the knowledge of 
tumors of the breast and their management.  ‗Virchow‘ (1821 – 1902) 
differentiated benign and malignant tumors by their cellular structures, 
and stated that any benign tumor cell can become malignant if it is 
subjected to irritation.  ‗Samuel-W-Gross‘ was in belief and stated that 
benign tumors of the breast & non invasive carcinoma can be cured, if 
they are operated early. In 1905 Collins Warren brought a paper on 
benign tumor of the breast & their classification. That was the first paper 
entirely devoted on benign tumors of the breast. And also he advised only 
local excision is sufficient for these benign tumors.  ‗Hughes‘ and 
‗Mansel‘ (1982) have brought out a paper about Etiology and 
management of benign disease of the breast.  
In present century workers like Cheatle. Cutler, Thackeray, 
Handly, Markwitz, baker, Harrington, miller, Stewart, Friedman, Tayler, 
Lettes-J-collins and still more scientist have contribution in understanding 
of aetiology nature & the treatment of benign tumors of breast.  
 8 
ANATOMY 
EMBRYOLOGY  
During the 6th week of Intrauterine life of the human Embryo, a 
linear ectodermal thickening occurs along the line which is stretched from 
the axilla to the groin, on either side called ―Milk ridges‖ or milk streak 
or ―Galactic Band‖. 
 
Among the Milk Streak or Galactic band the portion in the region 
of the thorax forms the mammary primordium. The rest of the portion 
gets regressed. The mammary primordium undergoes a number of stages 
to form the mammary gland.  They are 
          1.Milkhill stage 
          2.Disk stage 
          3.Globular stage 
          4.Budding stage 
          5.Branching stage 
 
The secondary mammary changes then develop.The adult female 
breast is also a‗modified apocrine sweat gland‘. Then 
            6.Canalization stage and 
            7.End vesicle stage 
 9 
 
Pict.–1: Mammary gland development. Anterior and lateral views of the 
breast are shown in columns 1 and 2. The microscopic appearance of the 
ducts and lobules are illustrated in column 3 and 4, respectively. Panals: 
A - Prepubertal (childhood), B – Puberty, C – Mature (reproductive), D – 
Pregnancy, E – Lactation, F – Post maenopausal (Senescent state) 
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 Pict. 2 : Anatomy and physiology of the normal and lactating breast         
                        
 
 
MORPHOLOGY OF NORMAL BREAST 
[Gross Anatomy of Breast] 
 
The breast is located within the superficial fascia of the anterior 
thoracic wall, the adult breast lies between the second and sixth ribs in the 
vertical plane, from lateral edge of the sternum to mid axillary line in 
horizontal plane. The deep portion or posterior surface rests on portions 
of deep investing fasciae of the pectoralis major, serratus anterior and 
external oblique and upper extent of rectus sheath. The average breast 
measures (base) 10 to 12cm in diameter and 5 to 7 cm thickness. A 
typical non lactating breast weighs between 150-225gms, the lactating 
breast exceeds 500gms. The shape or contour of the nulliparous female 
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breast has a typical hemispheric, with distinct flattening above the nipple. 
The multiparous women‘s breast, with hormonal stimulation associated 
with pregnancy and lactation is usually larger and pendulous. The contour 
is been explained by the orientation of the base of the breast and depends 
on the shape of the thorax. A portion of the breast tissue projects into 
axilla called as ―Axillary tail of spence‖ The breast consists of 3 major 
structures. 
a) skin, 
b) Subcutaneous tissue 
c) Breast tissue with parenchyma and stroma. 
 
The  breast parenchyma composed of 15-20 segments. Nearly 5-10 
major collecting ducts open in to nipple . The branching system may be 
named in a logical fashion. Starting with ducts from the nipple to the 
ducts draining each alveolus, the nomenclature of breast Epithelial 
System is as follows. 
 
Major Ducts : 
- Collecting ducts 
- Lactiferous sinuses 
- Segmental ducts 
- Sub-segmental ducts 
 12 
 
Terminal Duct – Lobular unit : 
- Terminal ducts 
- Extra lobular 
- Intra lobular 
- Lobules 
According to this collecting duct drains the segmental ducts, 
segmental ducts branch into a series of sub-segmental ducts in to which 
the terminal ducts drain. Each terminal duct supplies the single lobule 
forming terminal duct lobular unit [TDLU] of Wellings (1975).Many 
ductules arise from the terminal ducts. The extra lobular ducts are 
surrounded by elastic tissues and ordinary connective tissue. The lobules 
does not contain elastic tissue but it contains specialized loose vascular 
stromal tissue. 
 
           The larger ducts are sites of benign papilloma. TDLU are site for 
origin of fibroadenoma, in the development phase, cyst formation and 
sclerosing adenosis in involuntary phase. Intralobular portion of terminal 
duct are the site for carcinoma. 
 
         The breast skin like skin in other areas contains hair follicles,sweat 
glands and sebaceous glands. 
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          The nipple is a conical eminence, surmounted on the areola at its 
centre. Its position corresponds to a point in the 4th intercostal space, a 
little lateral to mid clavicular line in virgin; And it is altered in 1st 
pregnancy. Nipple is directed outwards and upwards, which makes it 
convenient to feed the baby. It is devoid of fat, and contains fibrous 
tissue, strands of smooth muscle fibers, which causes erection of nipple 
on mechanical stimulation. Lactiferous duct opens into its centre. 
 
        Areola is a pigmented area about 3cm in diameter around the nipple. 
It is hairless in females. It is rosy pink in virgins and becomes dark on 
first pregnancy during 2
nd
 month and remains so far the last of the life. In 
pregnancy it enlarges to about twice its normal size and this enlarged 
areola is known as the second areola. 
 
        Areola has sebaceous glands and they appear as tubercles and these 
are known as areolar glands or ‗Montgomery glands‘. [Tubercles of 
Montgomery]. These glands provide lubrication during suckling. The oily 
secretion of the sebaceous glands is a protective lubricant during 
lactation. Facial tissue envelope the breast. The breast is enveloped by 
superficial pectoral fascia and under surface is covered by deep pectoral 
fascia. Both parts are connected by fibrous band called as suspensory 
ligament of cooper which supports the breast. 
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Blood Supply of the Breast 
The mammary gland is extremely vascular, the blood supply is 
derived mainly from the internal mammary and lateral thoracic arteries. 
Nearly 60% of the breast on its medial and central parts are supplied by 
the anterior perforating branches of the Internal mammary artery [Internal 
thoracic artery] 
Pict.-3 :  
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About 30% of the breast is supplied by the lateral thoracic artery on 
its upper, outer quadrant. The pectoral branch of the thoraco acromial 
artery and superior thoracic artery, (branches of axillary artery), the 
lateral branches of the 3rd, 4th and 5th intercostals arteries, and also 
subscapular and thoracodorsal arteries, all they make minor contribution 
in the blood supply of the breast. 
Venous drainage 
         The pattern of venous drainage is important, because of lymphatics 
follow the course of the blood vessels and also carcinoma of breast 
metastasizes through veins. The venous drainage consists of superficial 
and deep venous plexuses. These two anastamose via the inter-glandular 
system and at their periphery, the very superficial subdermal veins 
constitute the ―circle of Haller‖ around the areola. From here is formed a 
plexus with a very wide mesh, the ―Subcutaneous plexus of Haller‖ 
which drains in to the superficial veins of the region, 
 Above into superficial cervical plexus [Anterior and External 
jugular veins] 
 Laterally into cephalic vein via the thoracoacromial vein. 
 Below in to the superficial veins of the abdominal wall notably to 
superficial thoraco-epigastric by communication with the plexus of 
the opposite breast. 
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            Deep venous drainage accompanies the arterial flow. Intercostal 
veins course through the azygos and vertebral veins into superior vena 
cava. The internal thoracic perforators empty into the innominate veins. 
Pectoral perforators flow into the lateral thoracic vein, which ultimately 
reaches the axillary vein. The entire venous network of the breast is 
completely devoid of valves. 
LYMPHATIC DRAINAGE OF THE BREAST 
The primary route of lymphatic drainage of the breast is through 
the axillary lymph node groups. It is essential to understand the anatomy 
of the grouping of the lymph nodes in the axilla, but the boundaries of 
group of lymph nodes found in the axilla are not well demarcated. So 
there is a considerable variation in the names given to the lymph node 
groups. Anatomists usually define five groups of axillary lymph nodes. 
Surgeons identify Six Groups of axillary lymph nodes and three anatomic 
levels. The most commonly used terms to describe the axillary nodes are 
the following.  
   1. Axillary vein group 
   2. The External mammary group 
   3. The Scapular group 
   4. The Central group 
   5. The Subclavicular group 
   6. The Interpectoral or Rotter‘s group 
 17 
 
Pict.- 4 : Lymphatic drainage of the breast Schematic drawing of 
the breast identifying the position of lymph nodes relative to the breast 
and illustrating routes of lymphatic drainage. 
 
 The clavicle is indicated as a reference point. Level 1 lymph nodes 
include the external mammary (or anterior), axillary vein ( or lateral), and 
scapular (or posterior) groups; Level II, the central group; and Level III, 
the subclavicular (or apical). The arrows indicate the routes of lymphatic 
drainage. 
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Inter pectoral or rotters group: A group of nodes identified by 
surgeons and not by anatomists. These group consists of one to four small 
lymph nodes, that are located between the pectoralis major and minor 
muscles, and in association with pectoral branches of the thoroco-
acromial vessels. Lymph from these nodes enters the central and 
subclavicular nodes. 
Axillary lymph nodes are divided according to their lateral and 
medial relationships with the pectoralis minor muscle into three distinct 
levels and are defined as level 1,level 2, and level 3. 
Level 1 : Nodes are located lateral or below the lower border of the 
pectoralis minor, this level includes the external mammary, axillary vein 
and scapular lymph nodes groups. 
Level 2 : Located deep to or behind the pectoralis minor and 
include the central lymph node group and some of the subclavicular 
lymph node group. 
Level 3: Nodes are located superior or medial to the upper margin 
of the pectoralis minor and includes subclavicular (apical) lymph node 
group. 
Lymph Flow : To know the lymphatic drainage of the breast is 
essential to know the pathophysiology of the breast. Metastatic 
dissemination occurs predominately by lymphatic route. 
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Lymphatic flow is multidirectional through skin and mesenchymal 
[Intra parenchymal] lymphatics. The lymph vessels of the skin and 
parenchyma are valveless2.They accompany the veins for their flow, flow 
will be always unidirectional from periphery to right side of the heart. 
Lymphatic capillaries anastomose and fuse together to form fewer 
lymphatic channels, that terminates in the thoracic duct on the left side or 
smaller right lymphatic duct on right side, thoracic duct empties into left 
subclavian vein. And right lymphatic duct drains into right subclavian 
vein. Anson, Mcvay and  Hagensen found out two accessory directions 
for lymphatic flow from breast parenchyma to nodes of the apex of the 
axilla: 
1) Transpectoral and 2) Retropectoral routes. Lymphatics of the 
transpectoral route ie.,interpectoral nodes lies between the pectoralis 
major and minor muscles referred as―Rotter‘s nodes‖ route begins in the 
loose areolar tissue of retro-mammary plexus and interdigitate between 
the pectoral fascia and breast to perforate the pectoralis major muscle and 
follow the course of the thoracoacromial artery and terminate in the 
subclavicular (level III) group of nodes. 
Retro pectoral pathway drains the superior and internal aspects of 
the breast. These lymphatic vessels join lymphatics from the posterior 
and lateral surface of the pectoralis major and minor muscles, these 
channels terminate in the subclavicular [level III] group. 
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Three inter connecting groups of lymphatic vessels drain the breast. 
 A primary set of vessels originate as channels within the gland in 
the interlobular spaces and along the lactiferous ducts. 
 The vessels draining the glandular tissue and the overlying skin of 
the central part of the gland, pass into an inter connecting network 
of vessels located beneath the areola called as subareolar plexus. 
 A plexus on the deep surface of the breast communicates with 
minute vessels in the deep fascia underlying the breast. Along the 
medial border of the breast lymphatic vessels within the substance 
of the gland anastomose with vessels passing to parasternal nodes. 
More than 75% of the lymph from the breast flows directly to the 
axillary lymph nodes, while the remainder of the residual lymph passes to 
parasternal nodes. This anatomic facts provides support for the rationale 
for lymph node sampling of the axilla to determine the histological status 
of these nodes and by which the accurate staging by clinically or 
pathologically been done. Although some authorities have suggested that 
the parasternal nodes receive lymph primarily from the medial part of the 
breast but, Turner-Warwick reported that both the axillary and the 
parasternal lymph node group receive lymph from all quadrants of the 
breast with no specific tendency for any quadrant to drain medially or 
laterally. The skin of the breast drains via the superficial lymphatic 
vessels to the axillary nodes. The anterolateral chest and upper abdominal 
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wall above the umbilicus demonstrates a specific direction of flow 
towards the axilla. Below the umbilicus [establishes a ―Watershed‖] 
superficial lymphatics carry lymph to the inguinal lymph nodes. 
Lymphatic vessels near the lateral margin of the sternum passes through 
intercostal spaces to the parasternal lymph nodes that are associated with 
the internal thoracic vessels. In the upper pectoral region small number of 
lymphatic vessels pass over the clavicle to inferior deep cervical lymph 
nodes. 
 
The lymphatic vessels of the deeper structures of the thoracic wall 
drain primarily into 3 groups of lymph nodes.  
1) Parasternal  
2) Inter costal  
3) Diaphragmatic.  
 
  The parasternal or internal thoracic lymph nodes are a group of 
smaller lymphatics positioned about 1cm lateral to the sternal border in 
the intercostal spaces along the internal mammary vessels. 
 
The intercostal lymph nodes represent a small group located in the 
posterior part of the thoracic cavity within the intercostal spaces near the 
head of the ribs, one or more nodes are found in each intercostal space 
with relationship to the inter costal vessels. These nodes receive deep 
 22 
lymphatics from the postero-lateral thoracic wall, including  lymphatic 
channel from the breast. 
        The diaphragmatic lymph nodes located on the thoracic surface of 
the diaphragm. The anterior group includes two or three small lymph 
nodes also known as prepericardial nodes; that are located behind the 
sternum at the base of the xiphoid process. Efferent lymphatics from the 
anterior diaphragmatic nodes pass to the parasternal nodes. The lateral set 
of diaphrgmatic lymph nodes is comprised of two or three small nodes on 
each side of the diaphragm adjacent to the pericardial sac; where the 
phrenic nerve enter the diaphragm. They lie near the vena cava on the 
right side and near the esophageal hiatus on the left. The posterior set of 
diaphragmatic nodes consists of a few lymph nodes located next to crura 
of the diaphragm. These nodes receive lymph from the posterior aspect of 
diaphragm and convey it to the posterior mediastinal and lateral aortic 
nodes. 
The causes for breast masses range from localized benign 
nodularity to malignancy.  Most common benign lesion is Fibroadenoma. 
Invasive ductal carcinoma type of breast carcinoma is most common.  
For the past several years carcinoma of the breast has been the 
most common malignancy in woman. However, of all the breast lesions 
only 40% prove to be malignant Mac Donald.
5
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Most agree that there is basic association between benign & 
malignant lesions. Cystic diseases of the breast are the most common 
benign lesions. Almost 95% of the mammary lesions will be found to be 
one of the diagnostic big three Mac Donald
5
.  Viz (1) cystic conditions of 
the breast (ii) Fibroadenoma (iii) carcinoma.  
 
Disease Frequency (Mac Donald
5
) 
 
S.No. Name of disease No. of patients Percentage 
1. Cystic diseases 609 45 
2. Carcinoma 537 40 
3. Fibroadenoma 88 7 
4. Other lesions 111 8 
 
Out of an estimated total of 51.3 million deaths in the world during 
1996, more than 7.1 million are attributed to cancer. According to 
W.H.O. estimates, by the year 2000, the number of cancer deaths may go 
up to 80 million annually.
6
 The eight leading cancer killers worldwide 
(figure I ) which are also the most common in terms of incidence, account 
for about 60% of all cancer cases and deaths.
9
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Figure I: Ranking order by site of 8 selected cancers 
Rank Males Females Total (Both sexes) 
1. Lung Breast Lung 
2. Stomach Cervix Stomach 
3. Colon/rectum Colon/rectum Liver 
4. Prostate Stomach Colon/rectum 
5. Oral Lung Esophagus 
6. Liver Oral Cavity Breast 
7. Esophagus Ovary Oral Cavity 
8. Bladder 
Body of the 
uterus 
Cervix 
Source: 128 
 Breast cancer is the commonest cancer among females in the 
developed world followed by cancer of the lung. In 1998 the incidence of 
breast cancer in the United States was 29.7% of all the cancers of the 
body.
8
 It was also the leading cause of cancer deaths in women in United 
States until 1986 when it was surpassed by carcinoma of the lung
9,
 and 
currently it stands as the second most common cause of cancer death in U.S.  
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In India, as in other developing countries (data available till 1996) 
cancer of the cervix is the commonest cancer in females closely followed 
by cancer of breast (figure-II), although in some areas like Mumbai the 
incidence of breast cancer has overtaken that of cervical cancer 
Mitra
10
.They have predicted there will be around 85,000 new breast 
cancer cases each year in India. 
 
Figure-II Burden of cancer, 1996 (in thousands) 
Site Male Female Male Female Male Female 
Lung 510 168 477 164 760 229 
Stomach 226 147 408 231 486 290 
Colon-rectum 273 282 171 149 243 252 
Liver 65 34 309 131 263 123 
Breast 
(female) 
0 494 0 416 0 376 
Esophagus 54 20 266 141 235 123 
Mouth-
Pharynx 
96 32 288 160 207 117 
Cervix 0 102 0 421 0 247 
Prostate 289 0 111 0 194 0 
Bladder 128 41 108 33 105 38 
Ovary 0 91 0 100 0 129 
Body Of 
Uterus 
0 104 0 69 0 67 
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EPIDEMIOLOGY AND ETIOLOGY 
Various epidemiological factors some of which have been related 
to the etiology of breast cancer are discussed:  
INTERNATIONAL VARIATION 
While considering whole world, the incidence rate of breast cancer 
seen more in North American and North European countries .South 
Europe and South America are in intermediate state and the lowest rates 
seen in Asians and Africans. A woman living to the age of 80 years in 
North America has 1 in 9 chance of developing invasive breast cancer, 
whereas Asian women have one-fifth to one-tenth the risk of women in 
North America or Western Europe.
11
 
 
RISK FACTORS FOR CANCER BREAST 
1.  Age: rate of breast cancer with respect to age. 
Age in years Ratio of  breast cancer 
30 1 out of 2,525 
40 1 out of 217 
50 1 out of 50 
60 1 out of 24 
70 1 out of 14 
80 1 out of 10 
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2. Marital, Reproductive and Breast Feeding History:  
Many studies have shown that nulliparous females are at increased 
risk for breast cancer than multiparous females and the risk is higher in 
females who bear their first child at 30 years of age or more. The 
nulliparous females are 30% to 70% more likely to develop breast cancer 
than multiparous females. Moreover, females who have had their first full 
term pregnancy at the age of 18 years have a risk about one third that of 
females who have first full term pregnancy at more than 35 years.  
 
The chance of developing breast cancer is less in married female. 
Importance of the child bearing function in marriage was demonstrated in 
MackIin’s study in which nulliparous females had an equal incidence of 
breast cancer whether married or single further illustration that the 
married state is important only in its exposure to certain physiological 
variables.  
 
The higher percentage of breast cancer among mothers who never 
did nursing than among controls, suggested that breast cancer patients 
had a protective effect possibly by suppressing ovarian function
12
.  
Best sum up the effect of ‗age at marriage‘ ‗parity‘ and ‗nursing 
habits‘ on the occurrence of breast cancer. They showed that breast 
cancer is much more frequent in Parsee women (50%) who marry late at 
an average age of 25, have few children whom they often do not nurse; as 
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compared to Hindu women (14%) who are very poor, marry early at an 
average age of 16 and have numerous children whom they usually 
nurse.
13  
 
3. DIETARY INFLUENCE  
The committee on diet, nutrition & cancer of the National 
Academy of Science concluded that causal relationship exists between 
dietary mammalian fat & the incidence of breast cancer. Both the quality 
& quantity of dietary fat influence the incidence of this disease. Diet, high 
in fat including alcohol, increases the risk of developing the disease.
    
Vitamin A analogue may be used for breast cancer prevention – (Journal 
of American cancer society, July 2000). 
4. HORMONAL INFLUENCE  
The use of combined oral contraception doesn‘t have effect on 
breast cancer risk, when used by women of 25 to 39 years age.
16
  
Lipnick et a1
17
 noted an adverse effect when taken for prolonged 
period at a very early age or taken before the first full term pregnancy.  
Vessey
18
 concluded from his studies that estrogen use by 
perimenopausal & postmenopausal women for hormonal replacement 
may slightly increase the risk. 
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5. OBESITY  
The risk for obese women is 1.5 to 2 times higher than for non-
obese women. This relative risk is restricted to postmenopausal 
individuals.  
 
6. GENETIC FACTORS  
Lynch et a1
19
 documented the frequency of sporadic, familial & 
hereditary breast cancer variants. The risk for developing hereditary 
breast cancer is determined by pedigree, appears to be independent of age 
at first pregnancy and is higher when a biopsy confirms atypical 
hyperplasia. 
BRCA 1 a major breast cancer susceptibility gene, is present in 
most familial breast & ovarian cancer.  
BRCA 2, other major breast cancer susceptibility gene is linked to 
most familial male hereditary breast cancer.  
Lilienfeld
20
 summarized the results of eight studies, six of which 
showed a familial tendency to breast carcinoma. According to him the 
average probability of breast cancer in mothers of probands is 
approximately double that of the general population and that in sisters 
somewhat greater- roughly two and a half times the risk in general 
population.  
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Reports of symmetrical mammary cancers in homologous twins, 
several of which have been cited by Haagensen
3
 have added strength to 
the inference of an inherited factor. Simultaneous primary malignancies 
in both breast found in l% of cases could be because of the genetic 
influence or because of the characteristics of the specific type of breast 
cancer e.g. lobular carcinomas are known to be multicentric in origin and 
bilateral.  
 
Breast cancer has been known to occur in association with other 
cancers. Taylor was the first in 1931 to report an association between 
endometrial cancer and cancer of the breast (which may be related to 
hormone dependence). It has been noticed that multiple primary cancers 
involving breast, endometrium and ovary occur more frequently than 
would be expected by chance. 
21,22,23 
Women who have cancer of one of 
these sites have about twice the risk of cancer in another of these sites. 
Approximately 3.4% of 668 mammary cancer patients reported by 
Haagensen either previously or subsequently had malignant disease of 
another organ; the most frequent site was the uterus, followed by colon 
and rectum.  
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Irradiation data suggest that women exposed to ionizing radiation 
from infancy to age ten have an increased risk. Evans et al
24
 less than l% 
breast cancer cases results from diagnostic radiological procedures 
radiotherapy for breast cancer may increase the risk for contra lateral 
breast cancer
25
. Risk of breast cancer is reduced after radiation treatment 
for carcinoma cervix as a result of reduction of estrogen.
26 
 
Exposure to radiation as for therapy of Hodgkin‘s lymphoma 
(>3600 cGy) or multiple fluoroscopies (200-300 cGy) especially at 
younger ages (<30 years) poses an increased risk of breast cancer. 
11 
7. Benign breast disease and its association with breast cancer:  
The term benign breast disease includes fibrocystic disease, 
fibroadenoma, cystosarcoma phylloides and a long list of other rare 
benign diseases including epidermoid cyst of breast.
91
 
The incidence of fibroadenoma ( ―chronic mammary tumors‖ - as 
they were initially called by Sir Astley Cooper ) in Indian literature varies 
between 40-87% and it is not related with increased risk of cancer.
27 
 
The incidence of cystosarcoma phylloides varies widely in India 
from O.6%
28
 to 14.2%
29
. It has a special place among breast tumors 
because of its peculiar features-it is a locally malignant tumor, usually 
presents as a large breast lump in middle aged women and is diagnosed 
by its characteristic microscopic appearance. It does not increase the risk 
of breast cancer although rarely it can itself metastasize.  
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Fibrocystic disease has increased risk for breast cancer and this 
increased risk has been found to persist at least 30 years after the 
fibrocystic disease has been diagnosed. Large duct hyperplasia, epithelial 
hyperplasia or papillomatosis and various hyperplastic disorders have 
been shown to be associated with increased risk of breast cancer. Atypical 
hyperplasia associated with calcification has been particularly found to be 
in association with higher risks.  
In his series Mohan, 1997 found the following incidence of 
increased risk associate with benign breast diseases.
27 
Figure–III : Breast lesion with a probable increase risk of cancer. 
 No. Percentage 
Gross cystic disease 52 4.3 
Apocrine metaplasia 18 1.5 
Epitheliosis and atypia 4 0.3 
Atypical lobular hyperplasia 2 0.2 
Multiple intraductal papilloma 1 0.08 
Source : 84  
The relative risk of occurrence of breast cancer in various benign 
breast diseases was tabulated by Dupont
31
, a modified form of which, 
presented by Hansen and Morrow
32
 in 1998 is shown in figure-IV. 
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Figure–IV: Benign breast diseases and relative risk for subsequent 
invasive breast cancer.  
 
Classification  Relative Risk 
Nonproliferative lesions  
1 (no increase in 
risk) 
Cyst, micro or macro Fibrosis  
Duct ectasia Mastitis  
Fibroadenoma 
Metaplasia, 
squamous or apocrine 
 
Papillary apocrine  
changes 
Mild epithelial  
Mild sclerosing adenosis Hyperplasia  
Proliferative lesions  
1.5 – 2.0 (slight 
increase in risk) Moderate or florid 
hyperplasia 
 
Intraductal papilloma   
Florid sclerosing  
adenosis 
  
Proliferative lesions with 
atypia 
 
4.0 – 5.0 (moderate 
increase in risk) 
Atypical hyperplasia,   
Lobular or ductal  8.0 – 10.0 (high risk) 
Carcinoma in situ   
Ductal carcinoma in situ   
Lobular carcinoma in situ   
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All these changes occur in some but not all cancers, suggesting that 
the malignant phenotype is due to an accumulation of multiple changes 
rather than an orderly progression. Thus breast malignancy will present in 
any way from asymptomatic to distant metastasis. 
VARIOUS DIAGNOSTIC MODALITIES FOR BREAST LESIONS  
(A) CLINICAL EXAMINATION 
A complete clinical breast examination (CBE) is the first step to 
asses both breasts including chest, axilla and regional lymphnodes.  In 
premenopausal women CBE Should be delayed a week, because of breast 
engorgement during that period.  CBE done in upright and supine 
position.  In upright position breast can be visually inspected for 
asymmetry, nipple discharge, skin changes like oedema, thickening, 
dimpling, ulceration etc and any obvious mass, unilateral nipple inversion 
or retraction. 
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       In CBE ,Patient in supine position palpate both breasts, chest, axilla 
and neck in superficial, intermediate and deep tissue planes by TRIPLE 
TOUCH TECHNIQUE.  Nipple-areola complex to be assessed for any    
discharge. 
 
 
 
CBE sensitivity and precision can be strengthened by examining 
for long duration using three finger pads and in circular or radial direction 
in a systematic manner.   
 
Clinical breast examination can detect nearly half of breast cancers 
and one-third of lesion not detected in imaging. Despite its accuracy, 
Clinical breast examination should be followed by other investigations in 
all patients with breast masses.  
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A proper history and a thorough physical examination is the oldest 
and yet the most useful and indispensable method of diagnosis. As said 
by Haagensen
3
 a clinician who gives more importance to the results of 
newer diagnostic methods than physical examination of the breast is 
bound to make errors. 
Figure– V: Relative frequency of common clinical symptoms and signs 
in 100 consecutive patients with cancer of the breast. 
 
Symptom 
Order of appearance 
First 
Symptom 
Second 
Symptom 
Third 
Symptom 
Frequency 
Lump 78 9 1 88 
local pain 12 28 8 48 
Enlargement of lump  16 4 20 
Lump in axilla 4 3 1 8 
Soreness of nipple 6 2 0 8 
Discharge from nipple 4 2 2 8 
Retraction of nipple 1 5 2 8 
Ulceration 0 5 0 5 
Enlargement of breast 1 3 0 4 
Attachment to skin 0 2 0 2 
Weight loss 0 0 3 3 
Hemorrhage 0 0 1 1 
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Patients with breast disease may present with a variety of clinical 
complaints, the most common amongst these are : breast pain, nipple 
discharge and a palpable mass.
32
 Overall, breast pain is the most common 
breast symptom causing women to seek medical attention whereas breast 
mass is the commonest presenting symptom of cancer of the breast.  
The relative frequency of common clinical symptoms and signs in 
100 consecutive patients with cancer of the mammary gland has been 
reported by Ackerman (Figure V).
34
  
The Ellis Fischel State Cancer Hospital (EFSCH) reported the 
initial symptoms of mammary cancer in a series of 774 patients as 
follows:- 
Figure. VI: Initial Symptoms of Mammary Carcinoma reported in 774 
patients at the ELLIS FISCHEL STATE CANCER HOSPITAL. 
 
Symptom No. of cases %age of Total 
Painless breast mass 515 66 
Painful breast mass 87 11 
Nipple discharge 69 9 
Local edema 31 4 
Nipple retraction 27 3 
Nipple  crusting 15 2 
Local erythema 7 1 
Swelling of breast 6 1 
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Breast abscess 5 1 
Axillary mass 2  
Simultaneous  breast 
and axillary masses 
2  
Ulceration of the 
breast 
2  
Itching of the nipple 1  
Breast pain 1  
Axillary ulcer 1  
Arm swelling 1  
Puckering of the skin 
of the  breast 
1  
Echymosis of the  
breast 
1  
 
Source: 109 
Breast Pain 
Mastalgia, the most common breast symptom is more common in 
premenopausal than postmenopausal women and is rarely associated with 
breast cancer.  
Preece
35
 reported that 15% of 240 patients with operable breast 
cancer had breast pain as a presenting symptom, but only 16 patients 
presented with mastalgia alone. Breast pain has been related to the 
hormonal milieu of the breast and the unsuggested causes include an 
imbalance between estrogen & progesterone with excessive estrogenic 
stimulation of the breast or a change in the response of the breast tissue to 
both estrogen and progesterone
36  
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As described by Hansen and Morrow
32 
mastalgia could be cyclic 
or noncyclic. Cyclic mastalgia which is more common of the two is 
associated with the menstrual cycle and is maximal pre-menstrually. This 
cyclic pain is usually bilateral, poorly localized and described as 
heaviness in the breast. It occurs more commonly in younger women and 
usually resolves spontaneously. Non cyclic mastalgia on the other hand is 
most common in women in their 40‘s and is often unilateral and 
described as a sharp burning pain which appears to be localized within 
the breast. Non-cyclic mastalgia is usually secondary to an underlying 
breast lesion which should be treated. It has been suggested that in a 
patient with persistent, localized breast pain, the possibility of breast 
carcinoma should always be excluded.  
Nipple Discharge:  
Hansen and Morrow
32 
suggested that this common complaint is 
usually due to a benign process. It has been reported in 1O% to l5% of 
women with benign diseases and in 2.5% to 3% of women with 
carcinoma.
11
 The first step in the evaluation of nipple discharge is to 
determine whether it is physiologic or pathologic. Physiologic discharges 
are characterized by- discharge only on compression, multiple duct 
involvement and often bilaterality. Discharges are classified as pathologic 
if they are spontaneous, bloody, or associated with a mass. These 
discharges are usually unilateral and confined to one duct. Spratt
37
 
 40 
suggests that nipple discharge in a non-lactating breast is an abnormal 
conditions. Duct papilloma is implicated as the commonest cause of 
abnormal nipple discharge.  
Abnormal nipple discharge has been reported by different workers 
as a sign of malignant disease in 18 to 47 percent of Cases.
8,38,39
 The 
characteristics of the discharge cannot be associated invariably with 
either benign or malignant process. In two third of the patients with 
mammary carcinoma reporting nipple discharge in the EFSCH series 
(figure VI) the discharge was bloody and in the remainder it was serous 
or cloudy. As a differential point Copeland
40
 pointed out that a sero-
sanguinous or bloody discharge is more often benign in patients less than 
50 years and is more often due to cancer in those more than 50 years.  
Breast Mass of all the patients presenting with breast masses at least 30% 
have no disease.‖  
Fibroadenoma or ‗breast mouse‘ as it is often called occurs mostly 
between 20 and 50 years (it is the commonest tumor of the breast below 
35 years-Bailey and Love
41
 and is recognized by its characteristic 
clinical presentation of a well defined and an extremely mobile breast 
lump. It is usually solitary but may present as multiple lesions in 1O% to 
l5% of cases.
42 
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The non-proliferative lesions are associated with no increase in the 
risk of breast cancer development (fig. IV) and account for 70% of those 
palpable breast masses.
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Other signs:  
Apart from the above mentioned presentations other signs should 
also be carefully looked for
4
 viz. asymmetry of the breast, retraction of 
skin/nipple, ulceration, excoriation of the nipple, lump in the axilla. It is 
universally accepted now that axillary lymph node metastasis is the most 
important prognostic indicator of breast cancer.
3,41,43
 and size of the tumor 
is a good clinical indicator of the extent of axillary lymph node 
involvement.
44 
 
Two important nipple changes produced by carcinoma are 
inversion and Paget‘s disease.45 Paget‘s disease of the nipple is one of the 
most visible but deceptive diagnostic signs of breast cancer. Haagensen
3
 
has described a useful clinical guideline for assessing lesions of the 
nipple  
 Lesions confined to the nipple only are almost always Paget‘s 
disease. 
 Lesions including nipple and areola and even surrounding skin are 
usually Paget‘s disease.  
 Lesions involving only areola or skin are benign dermatitis. 
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MALE BREAST CANCER  
Cancer of the male breast is rare and accounts for about 0.6% of all 
breast cancers.
41,89
 The most frequent types (about 90%) are invasive 
ductal carcinomas.
90
 An estimated 1400 cases of breast carcinoma in 
males versus 180,200 cases of breast carcinoma in females were 
diagnosed in the U.S. in 1997 (Parker). It has a similar natural history as 
that of female breast cancer. It‘s characteristic features are  
 
 The mean age at diagnosis of male breast cancer is 60 years which 
is 5-10 years later than in women.
46
  
 The commonest present complaint is a painless mass beneath the 
areola.  Other features will be same as in female like nipple 
discharge, retraction, ulceration, axillary swelling etc…  
 
 More or less all types of female breast cancer occurs in male 
excluding lobular variety.
47
 One case of lobular breast carcinoma in 
males has now been reported at Tata Memorial Hospital. The 
commonest histological type reported is infiltrating duct cancer 
84.8%
48
.  
 It shows an increased propensity to estrogen receptor expression.48 
Hormonal abnormalities resulting from liver disease increase the 
risk. 
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 Gynaecomastia is not a premalignant state; and men XXY 
phenotype have a 20-fold increase in the risk of breast cancer.
47 
 
 Stage for stage, male breast cancer carries the same prognosis as in 
females.  
Finally it must be mentioned that the clinician should develop a high 
skill in diagnosing breast cancer at an early stage. In this effort, it is 
important to keep in mind that five groups of women are particularly 
predisposed to develop the disease as outlined by Haagensen
3 
 
 Women who have a family history of breast cancer.  
 Women who have had gross cystic disease of the breast.  
 Women who have had carcinoma in one breast.  
 Women who have been found to have lobular neoplasia (lobular 
carcinoma in situ) in either breast.  
 Women who have had multiple papilloma in either breast.  
Moreover, Haagensen
3
 has also listed the common errors made by the 
clinicians, as a result of which they miss the diagnosis of breast cancer. 
They should always be kept in mind and are as follows - 
1) Treating the patient for some other disease when she or he will be 
having obvious tumor. 
2) Failure of the clinician, in his palpation of the breast, to feel the 
tumor that the patient had discovered and for which she came to 
consult him.  
3) Mistaking a carcinomatous tumor of the breast for a breast infection.  
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Mention must be made here of a special entity called ‗mastitis 
carcinomatosa‘ or Inflammatory carcinoma of the breast.49 It is 
characterized by rapid rate of growth along with pain, redness of skin, 
warmth and cutaneous edema and so it often mimics an inflammation of 
the breast. Apart from this, chronic consolidated breast abscesses which 
often present as a lump and mild pain may also simulate breast cancer.  
1. Wrongly diagnosing a carcinomatous tumor of the breast as a 
benign lesion, and failing to advise biopsy or excision.  
2. Careless treating of patients with acute sharp pain in breast.  
3. Disregarding a definite retraction sign.  
4. Not evaluating the reason for nipple discharge.  
5. Relying upon negative aspiration biopsy.  
6. Relying on mammography rather than palpation. 
(B) FINE NEEDLE ASPIRATION CYTOLOGY (FNAC)  
All patients with palpable breast masses are initially proceeded 
with FNA Cytology.in FNAC 22-to25-gauge needle is used. some cysts 
usually disappear with aspiration. Its better to image breast before FNA 
because of cyst wall disruption during aspiration. Otherwise after two 
weeks of FNA procedure you can go for imaging and better to intimate 
radiologists regarding FNA.  
FNA can be done under image guidance either steriotactically or 
sonographically. When sample is adequate the sensitivity of FNA goes up 
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to 99% for malignancy. Accuracy rate of FNAC depends on sample 
adequacy and physicians skill.so that its positive predictive value in 
malignancy goes up to 99% and negative predictive value may vary from 
86 to 99%.
 
Kun
50
 in 1847 described ―a new instrument for the diagnosis of 
tumors‖. In 1883 Leyden used needle aspiration for the diagnosis of 
pneumonia. Menetrier
51
 in 1886 was the first to use it for the diagnosis 
of lung cancer. Some years later in 1904, Greig & Gray
52
 diagnosed 
trypanosomiasis in lymph node aspirate from patients with sleeping 
sickness.  
There was then a lapse of papers on needle aspiration until 
Guthrie
55
 published his account in 1921 of using a 21 gauge needle, but 
it attracted little interest. The first ideological and practical impetus to 
aspiration cyto-pathology came in 1927 when Dudgeon and Patrick
54
 
proposed needle aspiration of tumors as a means of rapid microscopic 
diagnosis. This idea was taken up in early 1930s by Hayes E, martin
55
 
and Edward B. Ellis. The first large scale study was carried out by the 
pioneering team.
55,56 
In spite of their extensive work & experience FNAC 
did not become popular. It was however, the publications from the 
Radiumhemmet of the Karolinska Hospital in Stockholm that brought 
aspiration cytopathology to international attention and the highly 
influential work by Franzen and Zajiceck
57
 renewed interest in the 
procedure. 
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The procedure  
The fundamental requirement for FNAC of the breast is that a mass 
is palpable or that a mass has been identified by mammography,
58 
so that 
it can be approached under radiological guidance by a needle. Aspiration 
is best performed with a syringe in a Cameco syringe holder.
59
 Various 
refinements of this technique have been described such as the use of 
multi-hole needle
60
 or vacuum tubes as for venepuncture.
61
 Zaldela et 
al
62
 advocated employing only a needle for multiple punctures. Use of 
thin needles was popularized by European workers before which needles 
of thicker caliber were used.  
Staining is done either by May-Grunwald-Giemsa (MGG) stain on 
air dried slides (which better demonstrates the cytoplasmic detail) or by 
papanicolaou stain on alcohol fixed slides which gives excellent nuclear 
details.
63
 Some cytologists however prefer H and E slides.  
Advantages  
FNAC is a safe and quick technique which can be done on OPD 
basis with little equipment and cost. It causes minimal inconvenience to 
the patient. It is highly specific for the diagnosis of malignancy. On 
occasions it can be therapeutic. 
Disadvantages
59
: 
 A high degree of skills required  
 A percentage of aspirates are unsatisfactory.  
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 Classification of the type of cancers is sometimes difficult.64  
 Adequate material is difficult to obtain in very small breast lumps.  
 The most serious disadvantage of FNAC is that a negative report is 
unreliable.  
 Final diagnosis cant arrived with FNA report alone          
 
Complications  
Although the incidence of complications due to FNAC of breast is 
very less, they are known to occur
58
 and include  
 Pneumothorax — the most important and serious.  
 Haematomas at the site of needle aspiration are common and may 
result in false positive mammograms after aspiration and so a 
mammogram should be done after at least 2 weeks of FNAC.  
 Acute mastitis is a rare complication.65  
  Additional applications of FNAC: Apart from cytological 
diagnosis, the aspirated cells can also give other information. 
 Analysis of steroid receptors-estrogen and progesterone can be 
done using the immunoperoxidase technique.  
 Detection of tumor-associated antigens and other tumor related 
proteins employing immunoperoxidase technique e.g. cytokeratins, 
CEA, NSE, S-100 protein etc.  
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 Electron microscopy can also be applied for ultrastructural 
evaluation.  
 S-phase fraction by flow cytometry and DNA content of cells by 
morphometry can be calculated. These give information about the 
growth potential of the tumor cells and may predict the risk of 
recurrence.  
(C) MAMMOGRAPHY  
Mammography can be diagnostic and screening modality.  By 
using spot compression view and magnification view we can improve its 
accuracy. Diagnostic mammography is up to 87 percent sensitive in 
detecting cancer. Its specificity is 88 percent, and its positive predictive 
value may be as high as 22 percent. 
Mammography may be done either as a diagnostic or screening 
procedure. Woman more then 40 years can be imaged better with 
mammography because of less fibroglandular tissue 
A conclusion arised to screen women between 50 to 69 years using 
mammography as a results of one metanalysis, which shows 26% 
reduction in breast  cancer mortality among women screened at ages of 
50 to 74 
Screening women less then 40 years using some guidelines doesn‘t 
show better cancer detection rate.  
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In 1913 Albert Salomon
66
, a German surgeon, correlated the 
clinical, pathological and roentgenologic characteristics of 3000 
amputated breasts and noted many of the roentgenographic features of 
breast tumors. He was able to distinguish some infiltrating from non-
infiltrating carcinomas and to recognize some non-palpable breast 
cancers. Stafford 
Warren
67
, a radiologist, pioneered clinical mammography in 
1930‘s. However, mammography was never widely used because of 
technical difficulties.  
In the 1950‘s Raul Leborgne68 in Uruguay revitalized interest in 
mammography when he reported the radiographic appearance of 
carcinoma micro-calcifications and performed histopathologic 
correlations. Further work was done in 1950‘s by Jacob Gershon-Cohen 
in Philadelphia, who identified many features of benign and malignant 
lesions.  
In 1960 Robert Egan
69
 in Houston introduced a reproducible 
method of obtaining diagnostic X-ray examination of the breast using a 
high mili-amperage, low-kilovoltage technique and industrial film.  
In the mid 1960‘s the first x-ray unit designed for mammography 
was introduced by Gros
70
 in France. This dedicated mammography unit 
used a molybdenum anode for better soft tissue imaging and a breast 
compression device to eliminate motion and improve image quality.  
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Another important advance came in 1972 with the introduction of 
film screen mammography, which permitted rapid automatic processing, 
shorter exposure, and sharper images.
71 
 
The procedure 
Mammographic examination can be done for screening as well as 
for diagnostic purposes. In diagnostic mammography 2 views are taken 
for each breast cranio-caudal and medio-lateral oblique view. Usefulness 
of a third view-the oblique view, has also been described by Lundgren.
72 
 
 
The breast is compressed between two plates before taking the 
mammogram. Compression of the breast provides several advantages  
 Holds the breast motionless.  
 Separates the tissues to disclose small lesions.  
 Improves image quality by decreasing scattered radiation.  
 Reduces the radiation does by decreasing breast thickness.  
 
MAMMOGRAPHIC APPEARANCES  
Normal Breast:  
The breast consist of a glandular portion and fibro-fatty stromal 
portion. The fibro-glandular tissue appears radio-opaque whereas the 
fatty tissue radiolucent.  
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The breast of younger women consists mainly of dense fibro-
glandular tissue which appears radio-opaque and this often limits the 
accuracy of the mammogram. With increasing age and after child bearing 
the dense glandular tissue is replaced by radiolucent fat, allowing 
abnormalities to be detected more readily. Thus mammography is more 
useful in identifying lesions in fatty breasts of old females.
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Malignancy:  
The mammographic features of malignancy can be divided into 
Primary, Secondary and indirect signs.
74 
 
 
The primary signs include a mass of relatively high radiographic 
density, micro-calcifications or both. An irregular mass with spiculated 
margin is the most important mammographic feature indicating 
malignancy. The more highly infiltrative lesion, the more spiculated the 
margin will appear in the mammogram.
74
 The malignant calcifications 
may occur with or without a mass. The micro-calcifications are typically 
numerous and clustered, of various sizes and shapes, and may have a 
branching configuration. The greater the number of calcifications in a 
cluster, the greater the likelihood of malignancy. A cluster is defined as 
three or more calcifications in an area of 0.5 cm
2
. 
Secondary signs such as skin thickening and retraction are usually 
obvious clinically. 
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Indirect signs of malignancy that may be the only evidence of non-
palpable cancer include architectural distortion, the appearance of a neo-
density, parenchymal asymmetry and a unilateral focus of one or more 
prominent ducts. As many as 20% of non palpable breast cancers may be 
indentified on mammograms by subtle indirect signs.
95
 
 
Benign masses: 
 In contrast to Infiltrative margins of most carcinomas, the majority 
of benign masses such as cysts, fibroadenomas have sharply   
circumscribed margins. Benign calcifications are more often evenly 
scattered. Calcifications of fibroadenomas are usually coarse. 
 
Indications: Mammography is indicated as a diagnostic procedure.  
 When clinical finding are suspicious. 
 Prior to any breast biopsy. 
 For detecting occult breast cancer when axillary lymphadenopathy 
is the only presentations.
3
 
 
Disadvantages
74
:  
 Although mammography is highly sensitive in identifying breast 
cancers at an early stage it has poor specificity and so should not be 
solely relied on.  
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 Masses with spiculated margins are usually malignant but similar 
appearance may be seen in radial scars, sclerosing adenosis, 
posttraumatic fat necrosis. Calcifications of fibrocystic disease 
often mimic those of malignancy leading to unavoidable false 
positive results. Calcific-like deposits in the skin secondary to 
tattos, deodorants, ointments or sebaceous gland secretions can 
also be mistaken for malignancy.  
 Early mammograms resulted in a radiation dose of approximately 1 
to 4 rads. Today a two-view film screen examination leads to an 
average glandular dose of 0.04 to 0.08 rads. Although the doses 
used in mammography are very small, they are hazardous to those 
who are unusually sensitive to radiations eg. l-2% of persons with 
Ataxia-telangiectasia gene.  
 
Hardesty et al
77
 One important indicator of the quality of 
screening mammography program is positive predictive value PPV1. 
Optimal PPV1 depends on sensitivity and recall rate. Optimal (maximum) 
PPV1 can occur at any sensitivity level.it should not be followed as a sole 
indicator because it misses many malignant breast mass.  
 
Lee et al
78 
assessed the imaging findings of inflammatory breast 
cancer. They retrospectively analyzed the mammography, 
ultrasonography and magnetic resonance imaging (MRI) findings of nine 
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patients with inflammatory breast cancer. Inflammatory breast cancer 
showed skin thickening and nipple-areolar swelling on mammography, 
ultrasonography, and MRI. Tumor with lymphatic dilatation on 
ultrasonography and enhancement of thickened skin and parenchyma on 
MRI can be useful findings in the diagnosis of inflammatory breast 
cancer.  
 
(D) ULTRASONOGRAPHY (USG)  
Ultrasonography is mainly used to find out whether the mass is 
cystic or solid. The sensitivity of ultrasound goes up to 89% if the mass is 
cystic in nature.  Further investigations are needed only if cyst has 
malignant feature. 
Ultrasound images dense breast tissue better then mammography.
 
       Ultrasonography does not have a role as a single or initial study in 
screening for breast cancer. However it can be used if the mass is too 
small or too deep for FNA and if patient refuses FNA.  
If ultrasound diagnose simple cyst ,the risk of simple cyst going for 
malignancy is very low. One study found no cancers in 223 cysts. 
However, some experts recommend FNA if a simple cyst is found at the 
site of a palpable mass.
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Young women <30 years with high risk for malignancy like having 
family history, BRCA mutations can go for ultrasound imaging.
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The breast ultrasound is not approved by the U.S. Food and Drug 
Administration (FDA) as a screening tool for breast cancer because it is 
inferior to mammography. Mainly ultrasound is used to evaluate breast 
abnormalities detected in mammography and in those patients where 
mammography is contraindicated. 
 It has far lower sensitivity and specificity than mammography. 
The main limitations of USG include poor results with fatty breasts, 
inability to depict microcalcifications and inconsistent detection of solid 
lesions smaller than 1 cms.  
It is most appropriate for differentiating cystic from solid masses 
found by palpation or on mammograms, with high accuracy rates. The 
most diagnostic feature of a cyst is an anechoic interior. 
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Materials and Methods 
This is a retrospective study carried out in the department of  
General Surgery, Government Rajaji Hospital, Madurai Medical College, 
Madurai.. Patients presenting in the surgery OPD between August 2010 
to September 2012 with complaints of lump & other complaints in the 
breast who were admitted and subsequently operated were included in the 
study. The total number of cases studied were 80.  
The following protocol was followed in each case admitted with 
lesions in the breast  
(a) Clinical examination.  
(b) FNAC  
(c) Mammography  
(d) Ultrasonography  
(A) Clinical Examination: A detailed history was taken and thorough 
physical examination was done.  
Apart from the chief complaints along with duration of symptoms, 
family history, menstrual history and reproductive history was also taken.  
Examination consisted of general and local examination. Local 
examination included examination of both the normal and diseased 
breast. The site, size, shape and number of lumps, consistency, mobility, 
tenderness, skin changes and nipple changes, were noted. Routine 
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investigations were done preoperatively which included Hb%, TLC, 
DLC, Blood sugar, Serum creatinine, Liver function tests (in patients 
suspected of having malignancy), chest X-ray.  
 
(B) FNAC: The needle aspiration cytology was done in all patients 
before surgery.  
The cases selected gave the consent for the procedure and were 
investigated as follows.  
 
 Detailed clinical history including present and past illness.  
 Systemic examination and local examination with due care.  
 
Material: The following equipments were used  
 10 cc, 20 cc sterilized disposable syringe.  
 Disposable sterilized needle of 21, 22 and 23 gauge.  
 Spirit swab, clean glass slides, 95% alcohol as fixative agent, 
reagents for Haemotoxyline and Eosin staining.  
 
Method 
FNAC will be performed by 20 ml disposable syringe with 21 
gauges x 1.5 inches needle. Upon obtaining the material, aspirate will be 
smeared on slides. It will then be fixed in 95% ethanol. After being fixed 
the smear will be subjected to staining by hematoxylin eosin stain. In 
most cases adequacy of the aspirate was  assesed immediately.  
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The slide thus prepared was visualized under microscope for 
cytomorphological study. The cases were classified into categories 
according to their cytological features.  
(C) Mammography: Mammography was done in 80 cases.  
Material: Mammography was done by a machine specifically 
dedicated for the purpose-‖Mammography unit model III‖. It consists of a 
C-arm which can be moved in all directions. The distance between the X-
ray tube and the platform on which the breast rests remains fixed. 
Another movable plate made of plexiglass lies close to the platform and 
provides compression to the breast. The movement of the plate can be 
controlled by a foot switch. The X-ray dosages applied to the breast can 
be set automatically. As with all modern mammography units, grid is 
present to improve the image quality. The cassette for mammography 
contains an X-ray plate with the coating of the ultra sensitive material 
only on one surface (unlike conventional X-ray plates). Along with this is 
a film screen for absorbing the excessive radiations. 
Method: After explaining the procedure to the patient 
mammography was done in strict privacy in the presence of a female 
technician. Mammography is always done on both breasts and three 
views were taken for each breast (A) cranio-caudal view and (B) The 
medio-lateral view (C) Lateral medial view. The patient stands erect 
sticking as close to the device as possible. 
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Maximum portion of the breast was made to rest on the fixed 
platform and compression was provided by the movable plexiglass plate. 
The voltage, mili-ampere and the exposure time are automatically set 
depending on the density of the breast. The usual dosages employed are 
23-28 kv and 100- 400 mA. For an exposure period between 0.06 to 0.08 
secs, the head of the patient was turned to one side, the patient was asked 
to hold her breath and the mammography was taken. After viewing the 
other breast, the C-arm of the machine was rotated and a mediolateral 
view of both the breasts was obtained.  
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The plates were developed immediately and analyzed to see their 
quality so that repeat mammograms could be taken if required.  
(D) Ultrasonography  
Out of 80 cases, ultrasonography was done in all 80 cases.  
Ultrasonography of the breast is one of the imaging modalities 
used mainly to detect abnormalities in dense breast tissue like in young 
women. Basic physics is high frequency sound waves are directed 
through probe to breast which are reflected back as echo and images are 
created.  
Method:  
Always with clinical & mammographic findings of both breasts 
ultrasound should be proceeded.  
Ultrasound was done with a linear-array broadband transducer with 
a center frequency of 10 Mhz.In a larger breast a linear-array transducer 
with a center frequency of 7.5 MHz  are supplemented for better 
penetration. patient usually kept in supine position to scan inner region of 
breast. For the outer breast, the patient was placed in the contralateral 
posterior oblique position with the ipsilateral arm raised. Survey scanning 
was done in transverse and sagittal planes. Both radial and antiradial 
scanning planes were used to measure discrete lesions. When multiple 
suspicious lesions were noted and to calculate distance between lesions 
panoramic view was used. 
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Observation 
Eighty cases of breast lesions were included in this study and an 
attempt was made to differentiate them into two broad categories-the 
benign (including cystosarcoma phylloides) and the malignant by:  
 
(A) Clinical examination  
(B) FNAC  
(C) Mammography  
(D) Ultrasonography  
 
(A) CLINICAL EXAMINATION  
Following observations were made with regards to clinical 
examination of all the eighty cases included in this study.  
 
(I) Age: The age of the patients varied from 13 to 70 years. The 
youngest patient with benign breast lump was 13 years and the oldest 45 
years; and with malignant breast lump was 35 years and 70 years 
respectively. The 45-year-old patient with benign breast disease was of 
cystosarcoma phylloides. The oldest patient with fibroadenoma was of 35 
years of age. 27 out of the 31 cases of benign lumps were below 30 years 
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whereas 43 out of 49 cases of malignancy were between 30-60 years of 
age. An increase in incidence of malignancy was noted with advancing 
age as shown in the following table:  
TABLE 1 
AGE DISTRIBUTION OF CASES WITH BENIGN AND 
MALIGNANT BREAST DISEASES 
 
Age group (in years) 
No. of cases 
Benign Malignant Total %age 
11 – 20 10 0 10 11.6 
21 – 30 17 0 17 21.6 
31 – 40 3 14 17 21.6 
41 – 50 1 19 20 25.0 
51 – 60  0 10 10 30.0 
61 – 70 0 6 6 6.6 
 
(II) Sex:  All cases were females.  
(III) Religion: 70 patients were Hindus,8 were Muslims and 2 were 
Christians. All the 31 patients with benign lump were Hindus and 8 
Muslims and 2 Christian patients had malignancy. 
(IV) Socio-economic Status (SES): 70 patients were from low SES, 10 
belonged to middle class.  
(V) Marital Status: There were 8 unmarried patients, all of whom had 
fibroadenoma.  
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(VI) Menstrual History: Premenopausal – 44; Perimenopausal – 25; 
Postmenopausal – 11. 
Out of 80 female patients the menopausal status was as shown in 
the following table.  
TABLE 2 
MENOPAUSAL STATUS OF 80 PATIENTS  
WITH BREAST LESIONS 
 
Menopausal Status
  
No. of cases 
Benign Malignant Total 
Premenopausal 30 14 44 
Perimenopausal 1 24 25 
Postmenopausal 0 11 11 
 
35 out of the 49 patients with malignancy were peri or post 
menopausal and 14 were premenopausal. None of the patients with a 
benign breast lump was postmenopausal.  
(VII) Family History: None of the patients had a positive family history 
in 1st and 2nd degree relatives. 
(VIII) Symptoms and signs: Breast lump which was found in all the 80 
cases. Pain was the next most frequent symptom.  
On examination of the breasts, the clinical findings were 
confirmed. Axillary lymphadenopathy was found in 18 patients out of 
which 16 were of malignancy, and two cystosarcomas.  
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TABLE 3 
 
PRESENTING SYMPTOMS OF 80 PATIENTS WITH BENIGN 
AND MALIGNANT BREAST LESIONS 
 
 
Symptom 
No. of cases 
Benign Malignant Total %age 
(a) Local     
(I) Lump 31 49 80 100.00 
(II) Pain 13 16 29 36.25 
(III) Nipple Discharge 4 10 14 17.5 
(IV) Retraction of nipple 0 16 16 20.0 
(V) Ulcer 0 16 16 20.00 
(VI) Skin Edema 0 11 11 13.75 
(VII) Flattening of nipple 1 7 8 10.0 
(VIII) Lump in Axilla 2 16 18 22.5 
(b) Systemic     
(I) Anorexia 0 8 8 10.0 
(II) Weight Loss 2 14 16 20.0 
(III) Fever 0 7 7 8.75 
 
(IX) Duration of symptoms:  The duration of symptoms (from the time 
of first noticing the symptom to the time of presentation) varied from 1 
month to 5 years for benign and from 1 month to 4 years for malignant 
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disease. The average duration of symptoms for malignant disease was 
approximately 6 months.  
(X) Number of Lumps: Multiple (four) lumps were found in one 
patient of fibroadenoma. Rest of the cases had a single lump.  
(XI) Laterality: Left side was affected more than the right as shown in 
Table 4.  
TABLE 4 
 
DISTRIBUTION OF CASES ACCORDING TO THE SIDE OF 
INVOLVEMENT IN BENIGN AND MALIGNANT BREAST 
LESIONS 
 
Side 
No. of cases 
Benign Malignant Total % 
Right 10 23 33 41.25 
Left 14 26 40 50.0 
Bilateral 7 0 7 8.75 
 
 
Seven cases with bilateral fibroadenoma were operated on both 
sides. Bilaterality was not seen in any of the malignant cases. 
(XII) Site: As shown in Table 5 the lumps showed a predilection to the 
upper half of the breast being more distributed in outer and inner 
quadrants of the upper breast.  
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TABLE 5 
DISTRIBUTION OF CASES ACCORDING TO THE SITE OF 
INVOLVEMENT OF THE BREAST 
 
Part of Breast 
involved 
Benign Malignant Total %age 
Upper Outer 13 20 33 41.25 
Upper Inner 9 15 24 30.0 
Lower Outer 1 8 9 11.25 
Lower Inner 3 0 3 3.75 
Central 3 4 7 8.75 
More than one 
quadrant 
2 2 4 5.0 
 
(XIII) Accuracy: Clinical examination was accurate identifying the 
benign of lesions as 93.35% and malignant lesions as 89.80% 
respectively. 
TABLE 6 
DIAGNOSTIC ACCURACY OF CLINICAL EXAMINATION 
Type of lesions 
No. of cases 
Cytological 
diagnosis 
Correctly 
diagnosed 
clinically 
%age 
Benign 31 29 93.35 
Malignant 49 44 89.80 
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Graph–1: Diagnostic Accuracy Of Clinical Examination 
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  (B) FNAC:  FNAC was performed on all 80 patients 
preoperatively. The result of FNAC and their correlation with clinical 
cases are shown in table 7. 
TABLE 7 
RESULTS OF CYTOLOGICAL EXAMINATION 
No. of cases 
Correct Cytological diagnosis 
Clinical 
diagnosed  
% age 
(A) Benign    
 Fibroadenoma 27 27 100% 
Fibrocystic disease 2 0 0% 
Cystosarcoma phylloides 2 2 100% 
Total 31 29 93.55% 
(B) Malignant 49 44 89.80% 
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Graph–2:Results of Cytological Examination 
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TABLE 8 
ACCURACY OF FNAC IN 80 PATIENTS OF BREAST LUMP 
AND CORRELATION WITH HISTOPATHOLOGY 
 
No. of cases 
Histopathological diagnosis 
Cytological 
diagnosis 
% age 
Correct 80 80 100% 
Incorrect 0 0 0% 
 
(C) MAMMOGRAPHY:  Mammography was done on all 80 patients 
and the results were as follows: 
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TABLE 9 
MAMMOGRAPHIC DIAGNOSIS 
Mammography Diagnosis No. of cases 
Malignancy 49 
Fibroadenoma 25 
Phylloides tumor 2 
Fibrocystic disease 2 
Inconclusive 2 
 
 
TABLE 10 
ACCURACY OF MAMMOGRAPHY IN DIFFERENTIATING 
BENIGN AND MALIGNANT LESIONS 
 
 
No. of cases 
Cytological 
diagnosis 
Correctly 
diagnosed  
%age 
Malignant 49 48 97.96 
Benign 31 29 93.55 
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Graph 3 : Accuracy of Mammography in Differentiating Benign and 
Malignant Lesions 
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(D) Ultrasonography:   
Ultrasonography was done in 80 patients & the results were as 
follows: 
TABLE 11 
ULTRASONOGRAPHIC DIAGNOSIS 
Ultrasonographic Diagnosis No. of cases 
Malignancy 49 
Fibroadenoma 25 
Phylloides tumor 2 
Fibrocystic disease 2 
Inconclusive 2 
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TABLE 12 
ACCURACY OF ULTRASONOGRAPHY IN DIFFRENTITATION 
BENING AND MALIGNANT LESIONS 
 
 
No. of cases 
Cytological 
diagnosis 
Correctly 
diagnosed  
%age 
Malignant 49 49 100% 
Benign 31 29 93.55% 
 
Graph–4: Accuracy of Ultrasonography in Differentiating Benign and 
Malignant Lesions 
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Discussion 
The rising trend of breast cancer in India, the large number of 
diagnostic modalities available for its diagnosis and the extensive work 
still going on throughout the world in this direction-all suggest the need 
to develop a diagnostic procedure which could solve the problem of 
differentiating benign and malignant breast lumps and of detecting breast 
cancer at an early stage.  
The diagnostic methods that are most accepted today namely 
clinical examination, FNAC, Mammography and Ultrasonography are 
employed and accuracy of their results correlated.  
Of the 80 cases included in the study, 31 were benign and 49 were 
malignant on cytological examination. Thus, majority of the cases in our 
study were malignant. Of the 31 benign cases,27 were fibroadenoma, 2 
cystosarcoma phylloides & 2 fibrocystic diseases & in malignancy 42 
were infiltrating ductal carcinoma & remaining 7 infiltrating lobular 
carcinoma.  
On clinical examination, 27 out of the 29 patients of fibroadenoma 
were rightly diagnosed and they included 7 patients of juvenile 
fibroadenoma. All the 27 patients, diagnosed of fibroadenoma were 
below 30 years of age. This was in agreement with Haagensen’s3 study 
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in which the mean age of presentation of fibroadenoma was 31 years. 
According to Bailey and Love
41
, fibroadenoma is the commonest tumor 
of the breast below 35 yrs. The 7 patients of juvenile fibroadenoma were 
between 13-19 yrs. and had a common presentation of a huge  painless 
lump in the breast which was well defined and mobile. Sabiston
80
 has 
also mentioned that juvenile fibroadenomas occur as large masses in 
adolescent women. In fact because of their age of presentation, they have 
been called by Haagensen
3
 as ―Massive adenofibromas in youth‖.  
One case of fibroadenoma was misdiagnosed clinically as a case of 
malignancy of the breast. This 35 year old patient presented with a large 
painless lump of about 10 cm. in its maximum dimension with irregular 
margins, involving the outer half of the breast. The lump was slow 
growing and there was history of loss of appetite and weight. The lump 
was firm to hard in consistency. A provisional clinical diagnosis of 
carcinoma of left breast was made. Mammography of the lesion 
suggested it to be a fibroadenoma and lumpectomy was done. On HPE it 
was found to be a fibroadenoma with areas showing cystosarcoma 
phylloides like changes. This is just one of the examples of ―limitations 
of clinical examination‖ in the words of Haagensen.3 Such false positive 
diagnosis cause immense psychological trauma to the patient which can 
be averted by confirming the clinical diagnosis by further investigations 
before suggesting it to the patient.  
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A 45 year old patient who presented with a large mobile lump in 
her right breast was diagnosed clinically as cystosarcoma phylloides and 
this was supported by mammography. Wide local excision of the lump 
was done. But the same patient presented about three months later and 
was included in the study as a separate case. She was clinically diagnosed 
as a case of malignancy because of a short history in which the lump had 
recurred and gained an enormous size. The skin was red and ulcerated 
and there was a lump in the axilla. There was a definite history of 
anorexia and weight loss. Histopathology showed it to be cystosarcoma 
phylloides grade – 3. 
 
It is interesting to note that this case of cystosarcoma phylloides 
had some features in common with the case discussed earlier which was 
diagnosed clinically to be malignancy and histologically turned out to be 
fibroadenoma with areas showing cystosarcoma like changes. Both the 
cases occurred in middle aged females (35-40 yrs), both had a huge lump 
without axillary lymphadenopathy as the initial presenting symptom and 
both had a history of anorexia and weight loss. Another case of juvenile 
fibroadenoma which presented in a 14 yrs. old female as a huge lump, 
histologically showed fibroadenoma wih cystosarcoma like changes. 
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Several conclusions about cystosarcoma phylloides can be made from 
comparison of the above cases:  
(i)      Cystosarcoma phylloides may mimic a fibroadenoma in its early 
stages.  
(ii)     Cystosarcoma phylloides like changes are not infrequent in 
fibroadenoma which suggest that cystosarcoma may result from 
abnormal proliferation of the stromal component in an already 
existing fibroadenoma.  
(iii) Although it affects usually middle aged women, it may 
sometimes be present in young females when it cannot be 
distinguished clinically from juvenile fibroadenoma.  
(iv) Systemic symptoms of anorexia and weight loss may occur in 
cystosarcoma phylloides and may add to the difficulty in 
distinguishing such lumps from malignancy.  
(v)       High-grade cystosarcoma phylloides has a tendency to recur. 
Moreover Haagensen
3 
has also described the occurrence of 
phylloides tumor in young patients — rarely; although the typical age of 
presentation, as in our study is the fifth decade.  
Of the two other benign cases, two were of fibrocystic disease. The 
patient of fibrocystic disease was diagnosed clinically as duct ectasia 
because she had diffuse pain in both her breasts with a small lump in the 
upper and outer quadrant of the left breast near the areola; and she also 
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gave history of a turbid discharge from the nipple. In cases refractory to 
conservative treatment, excision of the lump was done and the FNAC 
revealed it to be fibrocystic disease.  
 
49 cases were of carcinoma breast. A correct clinical diagnosis of 
carcinoma was made in 44 out of the 49 cases, 5 cases were 
misdiagnosed.  
 
One case - a 35 years old female had a history of lump in her left 
breast in the infero-lateral quadrant for four months and turbid nipple 
discharge for three months. On examination, the lump was about 5 cm in 
diameter and was present close to the areola. There was no nipple 
discharge at the time of presentation. Diagnosis was difficult in this case 
and young age of the patient prompted to make a provisional clinical 
diagnosis of duct ectasia. Mammography of the patient was also not 
diagnostic. A descriptive report suggested a diagnosis of mastitis. FNAC 
of the lesion clearly showed it to be an infiltrating ductal carcinoma.  
 
Another patient of carcinoma breast presented at 35 years of age 
with a single mobile lump of about 2 cms in diameter in the upper and 
inner quadrant of her right breast. She was misdiagnosed clinically as 
fibroadenoma until her mammography showed an infiltrating duct.  
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The above two cases again highlight the inadequacy of clinical 
examination in detecting a typical presentations of breast carcinoma. As 
is obvious such false negative clinical diagnosis are much more ominous 
that the false positive diagnoses. Haagensen
3 
suggests that they can best 
be avoided by performing an FNAC or biopsy.  
 
  Thus two important features of our study need to be pointed out on 
the basis of clinical examination:  
1. It was possible to correctly diagnose 94% of the benign and 90% of 
the malignant breast lesions. According to Ackerman
34
 even the 
best clinician can diagnose breast cancer with an accuracy of 70%.  
2. In our study all the patients with breast cancer were married, had 
children whom they had nursed. It seems that these factors do not 
have much contribution to the causation of breast cancer in our 
society. This is in contrast to the findings of Khanolkar
13
 and 
Paymaster
81
 in a comparative study on Parsi and Hindu women.  
Clinical examination, as has been shown in our study and is also 
universally accepted, is indispensable and should always be done. 
Clinical diagnosis is highly accurate in our setup because  
i. Majority of the breast cancers in our society, due to various 
reasons, present at a late stage.  
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ii. They are quite easily palpable and in a majority of cases the 
diagnosis can be made clinically.  
 
FNAC : FNAC was done in all the patients of breast lumps in our study. 
FNAC showed the greatest accuracy (100%) as far as differentiation of 
benign and malignant cases was considered. It was able to diagnose all 
the 31 benign cases as benign and all the 49 cases of malignancy as 
malignant. However, a repeat FNAC was required in two cases of 
malignancy as in these, the material obtained on first aspirate was 
insufficient for diagnosis. An increase in the accuracy of the results by 
repeat FNAC has also been reported by Wilkinson
58
.  
 
Amongst the benign cases, all the 27 cases of fibroadenoma were 
rightly diagnosed by FNAC. However, as mentioned earlier, two cases of 
fibroadenoma on showed areas of cystosarcoma phylloides like changes 
which were not mentioned in the FNAC reports of these patients. There 
could be two reasons for this  
 
1. The needle might not have struck the area having cystosarcoma 
like changes and so it was not detected.  
2. If frank changes in terms of epithelial cells and stromal component 
are not present, differentiation between benign phylloides tumor 
and fibroadenoma may not be easy.  
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Shimizu et al
82
 reviewed the cytological features of 25 cases of 
phylloides tumor and 50 cases of fibroadenoma and concluded that 
cytological differentiation between benign phylloides tumors and 
fibroadenomas is possible not only from the stromal hypercellularity but 
also from the size and shape of epithelial clusters.  
 
In our study it was possible to diagnose a patient having 
cystosarcoma phylloides with grade III changes, on FNAC. This has also 
been suggested by Hayshi et al
83
 who said that it is possible to 
distinguish between benign and malignant phylloides tumors on the basis 
of increased density of abnormal stromal components.  
 
Two cases, fibrocystic disease were also subjected to FNAC. The 
case of fibrocystic disease was reported as duct ectasia. So an absolute 
diagnosis was not possible in these cases clinically. Thus in our study, the 
diagnostic accuracy of FNAC for benign lesions was 94%. Furniwal et 
al
84
 have reported an accuracy of 96% and Duguid
86
 has reported it to be 
77%.  
 
As far as a 100% accuracy for malignant cases is considered our 
results are comparable with the high accuracy rates reported for 
malignant lesions by different workers. 
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Furnival et al
84
 – 96% 
Russ et a1
85
 – 94% 
Duguid et al
86
 – 93.3% 
Abete et al
65
 – 93.1% 
Griffith et al
87
 – 98.7% 
 
Moreover this result is not surprising when we consider the fact 
that all these carcinomas had either grade II or grade III changes 
(Majority being grade III in which the cytological features of malignancy 
(cellular and nuclear) are obvious. Two important reasons which may 
result in fall in accuracy of FNAC in diagnosing carcinoma are  
 
i. Lesion is very small so that the needle did not hit the lesion.  
ii. There is very minimal atypia of cell which may at times be difficult 
to interpret.  
Both of these factors were not present in the present study group 
resulting in a high accuracy.  
 
Mammography: Mammography is currently considered to be a 
very useful tool in diagnosing breast lesions but it has its own drawbacks. 
As pointed out by Bassett the mammographic findings of malignancy 
may be found in certain benign lesions as well accounting for the false 
positive results (diagnosing cancer when it is not actually present). Also 
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breast cancers, because of their versatility may mimic a benign lesion 
mammographically accounting for the false negative results 
(misdiagnosing a case of cancer as a benign lesion). The mammography 
was done in 80 patients in our study.  
31 cases out of 80 in whom mammography was done were benign 
and 49 were malignant. Of the 49 malignant cases, 48 were diagnosed 
correctly by mammography on the basis of two distinguishing findings:  
 A lesion of increased density with speculated margins and  
 The presence of micro-calcifications present in clusters.  
One patient of malignancy was wrongly diagnosed as a case of 
mastitis due to lack of the above characteristic findings.  
Of the 31 benign cases, 25 were fibroadenoma, 2 cystosarcoma 
phylloides and 2 fibrocystic disease. 25 out of 27 cases of fibroadenoma 
were diagnosed correctly including five cases of juvenile fibroadenoma. 
The characteristic feature seen was a well defined opacity. 2 of these 
showed coarse scattered microcalcifications. Two case was reported as 
inconclusive because of lack of characteristic findings. In present study 
the accuracy of benign lesions & malignant lesions were diagnosed 
mammographically as 93.55% and 97.96% respectively.  
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ULTRASONOGRAPHY  
Although It is better to image women having dense breast tissue 
with ultrasound which is superior to mammography, it is not used to 
screen breasts. 
In our study ultrasonography was done in 80 patients of breast 
lumps. USG showed the greatest accuracy of 100% as far as 
differentiation of solid & cystic lesion was considered.  
Amongst the benign cases ultrasonography was done in all 80 
cases. 29 benign lumps were rightly diagnosed & two cases were 
inconclusive. Of the 49 malignant cases ultrasonography was done in all 
cases & which were also diagnosed correctly. 
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Conclusion 
This retrospective study was done to determine the usefulness of 
clinical examination, FNAC, mammography & USG in evaluating breast 
lumps.  
1. CLINICAL EXAMINATION  
Remains the gold standard and should unequivocally be employed 
as the first line method for diagnosing breast lesions. In our study, out of 
80 patients, 31 had benign lumps (27 fibroadenomas, 2 fibrocystic 
diseases, 2 cystosarcoma phylloides)  and 49  had malignant lumps.  
i. About 87.1% of the patients with benign lumps are within 30 years 
of age including 7 cases of juvenile fibroadenoma which are below 
20 years of age. Majority (87.76%) of the patients with malignant 
lesions are between 30 and 60 years of age and there is a rise in 
incidence with advancing age, upto 50 years of age.   
ii. Majority of the benign and the malignant cases are Hindus. 
iii. All the patients with Carcinoma breast married and had children (1-
5) whom they have breastfed. 29% are premenopausal and 71% are 
either perimenopausal or postmenopausal. None of the patients 
with Carcinoma breast have a positive family history.  
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iv. Pain is the second most common presenting symptom (36.25 %) in 
patients with breast lumps. It is more often associated with benign 
lumps. Nipple discharge is present in 17.5% of cases and is found 
in both benign and malignant cases. Flattening of nipple was found 
is one benign and 7 malignant lesions. Other symptoms of 
retraction of nipple, ulcer, skin edema, lump in axilla, systemic 
symptoms were associated with malignancy only. The duration of 
symptoms for benign lumps varied from 1 month to 4 years and the 
average duration of symptoms for malignant lumps was 
approximately  6 months.  
v. 50% of the lesions are left sided, 41.25% right sided and 8.75% are 
bilateral. Bilaterality is seen with benign lumps only in our study. 
Upper half of the breast is more commonly affected, the 
distribution of lesions being more in the outer than inner quadrants. 
vi. High grade cystosarcoma phylloides may present clinically as 
malignancy with axillary metastasis and in such cases clinical 
diagnosis of cystosarcoma phylloides is impossible.  
vii. Clinical examination is found to have an accuracy of 93.35% in 
diagnosing benign lumps and of 89.80% in diagnosing malignant 
lumps.  
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2. FNAC  
(I)  FNAC has a diagnostic accuracy of 100% in differentiating 
benign and malignant lumps. However, it is found that the exact 
diagnosis amongst benign cases is possible in only 93.55% of cases. The 
accuracy for detecting malignancy is 100% and is found to increase with 
increased number of aspirations.  
(II) Also, it is found that the diagnosis of cystosarcoma phylloides 
can be made on FNAC particularly if grade III changes are present but 
cystosarcoma like changes may be missed when present in association 
with fibroadenoma. 
 
3. MAMMOGRAPHY  
Mammography was done in 80 patients. It is able to detect 93.55% 
of the benign lumps and 97.96% of malignant lumps correctly.  
4. ULTRASONOGRAPHY  
Ultrasonography was done in 80 patients. The accuracy for both 
benign & malignant lump is 93.55% & 100% respectively.  
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Graph–5: Comparison of Sensitivity of Breast Mass lesions 
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After thorough study of each modalities clinical examination, 
FNAC, Mammography, Ultrasonography using 80 patients hospital 
record in retrospective manner, we concluded that for accurate diagnosis 
of breast mass lesions all CLINICAL EXAMINATION, FNAC, 
MAMMOGRAPHY AND ULTRASONOGRAPHY should be integrated 
in an orderly way by considering other factors like patients age, family 
history, size, duration of breast mass lesion etc and also physicians skill 
in all included techniques. 
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Summary 
From the very ancient period carcinoma breast has been one of the 
most common ailments affecting human civilization. It is the most 
common carcinoma causing death in females in western world whereas it 
is second most common cause next to carcinoma cervix in developing 
world like India
1
. Though carcinoma breast seems easier to diagnose and 
treat but till today it is a challenge for medical professionals to restrain 
this malignant disease.  
The use of the physical examination, mammography, and fine-
needle aspiration biopsy for diagnosing palpable lumps is referred to as 
―triple diagnosis.‖ There is excellent sensitivity (99%) and specificity 
(99%) with this approach.
2
 If any of these three modalities suggests 
cancer, excisional biopsy is warranted.  
A proper history and a thorough physical examination is the oldest 
and yet the most useful and indispensable method of diagnosis. 
Several irreproachable advantages of FNA cytology in assessment 
of breast lumps have made it the first line modality in the investigative 
sequence. Some of these advantages are
4
 : excellent patient compliance, 
short time required for planning of surgery and ancillary staging 
investigations without delay, avoidance of surgery in unequivocally 
benign conditions, equitable use of hospital and operation theatre 
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facilities with reduction in the need of frozen section, excisional or core 
needle biopsies.  
Roentgenography to identify breast diseases was first used in 1913 
at the University of Berlin. Since then, mammography has been widely 
accepted as a routine examination in the evaluation of breast diseases. 
Mammography is most widely used methods for detecting early breast 
cancer. 
Mammography is a special type of x-ray, used to create detailed 
images of the breast. Mammography uses low dose x- ray : high contrast - 
high resolution film; and an x-ray system designed specifically for 
imaging the breasts. 
Ultrasound is particularly useful in young women with dense breast 
in whom mammograms are difficult to interpret, and indistinguishing 
cysts from solid lesions. It can also be used to localize impalpable breast 
lumps.  
Ultrasound can be used to evaluate abnormalities in breast seen in 
mammography. Both detected and undetected breast mass by other 
modalities can go for ultrasound guided biopsy. Biopsy is highly accurate 
ways to evaluate suspicious masses within the breast that are visible on 
ultrasound, whether or not they can be felt on breast self examination or 
clinical examination. Ultrasound guided biopsy is most useful when there 
are suspicious changes on the mammography that can also be seen on an 
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ultrasound examination, but no abnormality can be felt on breast self 
examination or clinical examination by your primary care physician. 
 
The aims of the study are - 
1. To evaluate the various diagnostic modalities in breast mass lesion 
by FNAC, USG, Mammography and Clinical assessment. 
2. Utility and importance of integrated clinical, FNA Cytological, 
mammographical and Ultrasonographical approach in the 
diagnosis and work up of patients with breast mass lesion. 
 
This is a  retrospective study carried out in the department of 
general Surgery, Government Rajaji Hospital,Madurai medical 
college,Madurai,Tamil Nadu.Patients presenting in the surgery OPD 
between August 2010 to September 2012 with complaints of lump & 
other complaints in the breast who were admitted and subsequently 
operated were included in the study. The total number of cases studied 
were 80.  
This retrospective study was done to determine the usefulness of 
clinical examination, FNAC, mammography & USG in evaluating breast 
lumps.  
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1. CLINICAL EXAMINATION  
Remains the gold standard and should unequivocally be employed 
as the first line method for diagnosing breast lesions. In our study, out of 
80 patients, 31 had benign lumps (27 fibroadenomas, 2 fibrocystic 
diseases, 2 cystosarcoma phylloides)  and 49 had malignant lumps.  
i) About 87.1% of the patients with benign lumps are within 30 
years of age including 7 cases of juvenile fibroadenoma which 
are below 20 years of age. Majority (87.76%) of the patients with 
malignant lesions are between 30 and 60 years of age and there is 
a rise in incidence with advancing age, upto 50 years of age.   
ii) Majority of the benign and all the malignant cases are Hindus. 
iii) All the patients with CA breast married and had children (1-5) 
whom they have breastfed. 29% are premenopausal and 71% are 
either perimenopausal or postmenopausal. None of the patients 
with CA breast have a positive family history.  
iv) Pain is the second most common presenting symptom (36.25 %) 
in patients with breast lumps. It is more often associated with 
benign lumps. Nipple discharge is present in 17.5 % of cases and 
is found in both benign and malignant cases. Flattening of nipple 
was found is one benign and 7 malignant lesions. Other 
symptoms of retraction of nipple, ulcer, skin edema, lump in 
axilla, systemic symptoms were associated with malignancy only. 
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The duration of symptoms for benign lumps varied from 1 month 
to 4 years and the average duration of symptoms for malignant 
lumps was approximately  6 months.  
v) 50% of the lesions are left sided, 41.25% right sided and 8.75% 
are bilateral. Bilaterality is seen with benign lumps only in our 
study. Upper half of the breast is more commonly affected, the 
distribution of lesions being more in the outer than inner 
quadrants. 
vi) High grade cystosarcoma phylloides may present clinically as 
malignancy with axillary metastasis and in such cases clinical 
diagnosis of cystosarcoma phylloides is impossible.  
vii) Clinical examination is found to have an accuracy of 93.35% in 
diagnosing benign lumps and of 89.80% in diagnosing malignant 
lumps.  
 
2. FNAC  
(I)  FNAC has a diagnostic accuracy of 100% in differentiating benign 
and malignant lumps. However, it is found that the exact diagnosis 
amongst benign cases is possible in only 93.55% of cases. The 
accuracy for detecting malignancy is 100% and is found to increase 
with increased number of aspirations.  
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(II) Also, it is found that the diagnosis of cystosarcoma phylloides can be 
made on FNAC particularly if grade III changes are present but 
cystosarcoma like changes may be missed when present in 
association with fibroadenoma. 
3. MAMMOGRAPHY  
Mammography was done in 80 patients. It was able to detect 
93.55% of the benign lumps and 97.96% of malignant lumps correctly.  
4. ULTRASONOGRAPHY  
Ultrasonography was done in 80 patients. The accuracy for both 
benign & malignant lump was 93.55% & 100% respectively. 
 After thorough study of each modalities clinical 
examination,FNAC,Mammography,Ultrasonography using 80 patients 
hospital record in retrospective manner ,we concluded that for accurate 
diagnosis of breast mass lesions all  CLINICAL EXAMINATION,FNAC 
,MAMMOGRAPHY AND ULTRASONOGRAPHY should be 
integrated in an orderly way by considerin other factors like patients 
age,family history,size ,duration of breast mass lesion etc and also 
physicians skill in all included techniques. 
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PROFORMA 
Name   :    Age &  Sex   : 
IP No.  :    Unit  : 
Occupation  : 
Address  : 
Date of Admission :    Date of discharge : 
Age at menarche :    Age of menopause : 
Menstrual history : Regular / Irregular 
    Length of cycle 
    LMP 
Marital status  :    Parity : 
Breast feeding Details : 
 Whether each child was breast fed or not 
 If breast fed for how long ? 
Drug History    : HRT / OCP 
Family History  :  
Clinical findings        : 
Investigations             : 
Mammography report : 
FNAC report    or   : 
Ultrasound report 
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MASTER CHART 
 
Sl. 
No. 
Name 
Age/ 
Sex 
DOA IPNO Diagnosis Clin.Exm FNAC Mamo USG 
1.  MURUGESHWARI 35/F 27-08-2010 62549 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
2.  MEENA 70/F 27-08-2010 62079 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
3.  THANGAMMAL 38/F 31-08-2010 62616 CYSTOSARCOMA PHYLLOIDES RT  CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
4.  UNNAMALAI 70/F 31-08-2010 62529 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
5.  MURUGESHWARI 35/F 17-09-2010 64504 CARCINOMA RIGHT BREAST INCONCLUSIVE CONFIRMED INCONCLUSIVE CONFIRMED 
6.  VALLIAMMAL 59/F 17-09-2010 64583 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
7.  BANU 14/F 17-09-2010 81161 FIBROADENOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
8.  MEERA 13/F 24-09-2010 64826 FIBROADENOMA LEFT  BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
9.  RAJESHWARI 21/F 24-09-2010 65101 FIBROADENOMA LEFT  BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
10.  STELLA 38/F 13-10-2010 82142 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
11.  KALAVATHY 60/F 13-10-2010 66234 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
12.  LAKSHMI 68/F 15-10-2010 66458 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
13.  ABIRAMI 22/F 15-10-2010 67144 FIBROADENOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
14.  AMUTHA 19/F 22-10-2010 68224 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
15.  ESWARI 40/F 22-10-2010 92270 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
16.  KARTHIKADEVI 16/F 22-10-2010 208860 FIBROADENOMA RIGHT BREAST INCONCLUSIVE CONFIRMED INCONCLUSIVE INCONCLUSIVE 
17.  SHANTHI 59/F 11-11-2010 210134 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
18.  PATCHAIYAMMAL 59/F 22-11-2010 231120 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
19.  KALYANI 69/F 26-11-2010 235333 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
20.  KALA 50/f 26-11-2010 238642 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
 xiv 
 
Sl. 
No. 
Name 
Age/ 
Sex 
DOA IPNO Diagnosis Clin.Exm FNAC Mamo USG 
21.  PALANIYAMMAL 35/F 13-12-2010 234223 B/L FIBROADENOMA CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
22.  AARAYAMMAL 59/F 27-12-2010 61919 CARCINOMA LEFT BREAST INCONCLUSIVE CONFIRMED CONFIRMED CONFIRMED 
23.  SALEEMA 44/F 31-12-2010 213646 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
24.  THIRUMAGHAL 58/F 14-03-2010 233361 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
25.  SUNDARAVALLI 42/F 14-03-2011 241113 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
26.  MEENAKSHI 17/F 21-03-2011 78979 B/L FIBROADENOMA CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
27.  NAJEEMA 45/F 21-03-2011 73447 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
28.  MUNIYAMMAL 60/F 14-05-2011 80088 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
29.  KUMARI 45/F 14-05-2011 81201 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
30.  GANDHIMATHY 23/F 23-05-2011 11064 FIBROCYSTIC DISEASE INCONCLUSIVE CONFIRMED CONFIRMED CONFIRMED 
31.  UMADEVI 46/F 06-06-2011 14169 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
32.  PANCHAVARNAM 38/F 06-06-2011 14821 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
33.  KAMATCHI 47/F O6-08-2011 15010 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
34.  SHANTHI 48/F 16-08-2011 11386 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
35.  MEGHALA 24/F 20-08-2011 11742 FIBROADENOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
36.  SHANTHI 42/F 20-08-2011 11919 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
37.  LOGESWARI 18/F 20-08-2011 12141 B/L FIBROADENOMA CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
38.  SULTHANA 39/F 19-09-2011 12350 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
39.  RAJESHWARI 46/F 19-09-2011 12398 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
40.  NEELA 48/F 26-09-2011 13330 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
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41.  SUREKHA 35/F 26-09-2011 14321 FIBROADENOMA RIGHT BREAST INCONCLUSIVE CONFIRMED INCONCLUSIVE INCONCLUSIVE 
42.  LAKSHMI 25/F 26-09-2011 15111 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
43.  SHAKILA BANU 50/F 14-10-2011 15979 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
44.  SIVANAMMAL 39/F 14-10-2011 16212 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
45.  SUNDARI 50/F 21-10-2011 17773 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
46.  LAVANYA 15/F 21-10-2011 17780 FIBROADENOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
47.  INDHU 26/F 28-10-2011 18432 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
48.  MUMTAJ 50/F 28-10-2011 19001 CARCINOMA RIGHT BREAST INCONCLUSIVE CONFIRMED CONFIRMED CONFIRMED 
49.  REKHA 27/F 28-10-2011 20005 B/L FIBROADENOMA CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
50.  JOOHRA 48/F 11-11-2011 20100 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
51.  SUGANTHY 19/F 18-11-2011 20287 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
52.  SUNDHRAMBAL 46/F 18-11-2011 20312 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
53.  KAVITHA 60/F 18-11-2011 20363 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
54.  SWETHA 28/F 23-12-2011 20412 B/L FIBROADENOMA CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
55.  MOWNICA 29/F 23-12-2011 20443 FIBROADENOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
56.  SWATHI 24/F 23-12-2011 20497 
FIBROCYSTIC DISEASE RIGHT 
BREAST 
INCONCLUSIVE CONFIRMED CONFIRMED CONFIRMED 
57.  RADHIKA 35/F 13-01-2012 21521 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
58.  ANANDHI 29/F 13-01-2012 22213 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
59.  JYOTHI 39/F 20-01-2012 22311 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
60.  SUGANYA 45/F 23-01-2012 23333 CYSTOSARCOMA PHYLLOIDES RT  INCONCLUSIVE CONFIRMED CONFIRMED CONFIRMED 
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61.  SENTHAMARAI 51/F 23-01-2012 24800 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
62.  SELVI 42/F 27-02-2012 24823 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
63.  GOMATHY 30/F 27-02-2012 24901 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
64.  RAMYA 19/F 27-02-2012 25123 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
65.  SHARMILA 38/F 16-03-2012 26764 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
66.  NAVEENA 52/F 18-03-2012 26241 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
67.  ABINAYA 24/F 25-03-2012 26661 B/L FIBROADENOMA CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
68.  PRIYA 43/F 25-03-2012 26909 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
69.  SUBHASINI 70/F 15-04-2012 27132 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
70.  GAYATHRI 25/F 29-04-2012 27823 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
71.  INDHUMATHY 44/F 29-04-2012 27993 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
72.  FATHIMA 40/F 13-05-2012 28883 CARCINOMA RIGHT BREAST INCONCLUSIVE CONFIRMED CONFIRMED CONFIRMED 
73.  DHANALAKSHMI 26/F 13-05-2012 29001 FIBROADENOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
74.  VENNILA 40/F 24-06-2012 30005 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
75.  YOGESHWARI 27/F 24-06-2012 30152 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
76.  MEENAKSHI 70/F 29-07-2012 30332 CARCINOMA RIGHT BREAST INCONCLUSIVE CONFIRMED CONFIRMED CONFIRMED 
77.  KALIYAMMAL 40/F 29-07-2012 30531 CARCINOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
78.  JEYAM 25/F 21-08-2012 30785 B/L FIBROADENOMA CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
79.  THENMOZHI 14/F 21-08-2012 32211 FIBROADENOMA LEFT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
80.  THERASA MARY 38/F 18-09-2012 33369 CARCINOMA RIGHT BREAST CONFIRMED CONFIRMED CONFIRMED CONFIRMED 
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 1) Juvenile Fibroadenoma 
 
 2) Carcinoma Breast-Nipple Retraction 
 
3) Carcinoma Breast-peaud orange appearance 
 
4) Carcinoma Breast –Ulcer 
 
 5) Male Breast Cancer 
 
 6) Fibroadenoma of Breast 
 
7) Fibrocystic Disease 
 
8) Cystosarcoma phyllodes - Long clefts and myxoid cellular stroma 
 
  
9)Ggrade-III-Breast-Cancer-Cells 
 
10) FNAC-Breast Mass 
 
 11) Mammography machine 12) Mammography machine 
  
  
13) Mamography, Radiodense opacity with 
speculated margins MALIGNANT BREAST 
14) Mammography, Homogenous opacity-mediolateral 
view, BENIGN BREAST DISEASE 
  
 
 15)Ultrasound machine 16) Normal breasts 19) Fibrocystic disease 
 
 
 
17) USG-
Fibroadenoma 
18) USG-
Cystosarcoma 
Phyllodes 
  
  
20)USG malignant Breast 
 
 
